红景天苷衍生物的合成及其抗缺氧活性

为了寻找安全、高效的抗缺氧活性分子,以对羟基苯乙醇和1,2,3,4,6-β-D-葡萄糖五乙酸酯为起始原料,设计合成了25个新型红景天苷衍生物R1～R10、X1～X10、J1～J5,其结构经¹H NMR,¹³C NMR和HR-MS(ESI)表征,且均未见文献报道。采用H9C2心肌细胞缺氧/复氧模型对上述化合物进行体外抗缺氧活性评价,并通过人肾上皮细胞293T、人肺上皮细胞BEAS-2B、大鼠心肌细胞H9C2和人正常肝细胞LO2这4种细胞评价了体外抗缺氧活性较佳的化合物R7、X2、X8和J1的细胞毒性,最后通过常压缺氧小鼠模型,进一步评价了R7、X8和J1的体内抗缺氧活性。结果表明：R7、X8和J1表现出显著的体内外抗缺氧活性且无明显的细胞毒性。     

新型川芎嗪阿魏酸衍生物的合成及其抗血小板聚集活性

以阿魏酸及其类似物为原料,设计并合成了6个新型的川芎嗪阿魏酸衍生物,其结构经1H NMR,13C NMR,IR及MS表征.初步药理活性测试结果显示,部分化合物的血小板抑制率较高.     

新型布洛芬衍生物的合成及其抗炎活性

以布洛芬为原料,依次与草酰氯和氨基酸(2a~2d)反应制得中间体布洛芬衍生物(3a~3d);3与可缓慢释放H2S的5-对羟基苯基-1,2-二硫杂环戊烯-3-硫酮(4)经酯化反应,合成了4个新型的S-(+)-布洛芬衍生物(5a~5d)。α-溴乙酰氯与4经酯化反应制得5-(4-α-溴乙酰氧基)-苯基-1,2-二硫杂环戊烯-3-硫酮(6);6与1经偶联反应合成了一个新型的S-(+)-布洛芬衍生物(7),5和7的结构经1H NMR,IR和HR-MS表征。二甲苯致小鼠耳肿胀试验结果表明:5a,5c,5d和7均有较强的抗炎活性。     

新型常春藤皂苷元衍生物的合成及其体外抗HBV活性

以常春藤皂苷元为原料,对其3,23-羟基和28-羧基进行乙酰化、醚化、苯甲酰化及酯化等反应合成了8个常春藤皂苷元衍生物(2~9),其中6个未见文献报道,其结构经¹H NMR, ¹³C NMR, IR和MS表征。采用MTT法测定了2~9的体外抗HBV活性。结果表明：3~9随浓度增大,对细胞活力的抑制率明显增加,特别是7和9抑制率最明显,用药浓度为1×10^-6mol·L^-1时,抑制率均为9.46±0.47%。对2~9抑制Hep G2.2.15细胞表达表面抗原(HBs Ag)进行了测试。结果表明：2~9对HBs Ag的分泌表达有一定的抑制作用。     

新型苯丙氨酸三肽衍生物的合成及其抗乙肝病毒活性

以具有抗HBV活性的苯丙氨酸二肽化合物马蹄金素(MTS)为先导化合物,设计并合成了23个新型的苯丙氨酸三肽衍生物（4a~4h, 5, 6a, 6b和8a~8k）,其结构经¹H NMR, ¹³C NMR和MS(ESI)表征。采用HepG2 2.2.15细胞为乙肝病毒载体,评价了目标化合物的抗HBV活性。结果表明：化合物5（IC₅₀=2.98 μM）、 6b（IC₅₀=0.62 μM）和8k（IC₅₀=5.07 μM）对HBV DNA复制的抑制活性优于MTS（IC₅₀=11.16 μM）。     

含酰基哌嗪片段的呋喃查尔酮衍生物的合成及其抗炎活性研究

依据活性结构单元的拼合原理,以2-呋喃甲醛和4-氟苯乙酮为原料出发,经Aldol缩合、脱水、哌嗪取代反应生成4’-(1-哌嗪基)呋喃查尔酮(2)后,再与酰氯和磺酰氯反应,得到了10个未见报道的含哌嗪取代的呋喃查尔酮衍生物,其结构经~1H NMR和~(13)C NMR确证。采用小鼠巨噬细胞Raw 264.7模型初步测试了目标化合物的体外抗炎活性,结果表明,磺酰胺类化合物的抗炎活性要优于酰胺类化合物,特别是化合物4d能有效抑制NO的生成(IC_(50)=3.88μmol/L),与阳性对照药地塞米松活性相当。     

川芎嗪衍生物的设计、合成及抗血小板凝集活性研究

分别以川芎嗪(TMP)和邻苯二胺为起始原料,经KMn O4氧化、酯缩合、环化、还原等步骤合成了7个新型的川芎嗪衍生物,其结构经1H NMR、13C NMR及HRMS确证。并采用Born比浊法初步测试了化合物的体外抗血小板凝集活性。结果表明,化合物3和7对二磷酸腺苷(ADP)诱导的血小板凝集抑制率IC50分别为0.23mmol/L和0.27mmol/L,优于母体化合物川芎嗪(0.42mmol/L)。     

NO供体型马蹄金素衍生物的合成及其初步的抗乙肝病毒活性

以马蹄金素[N-(N-苯甲酰基-L-苯丙氨酰基)-O-乙酰基-L-苯丙氨醇,MTS]为先导化合物,设计并合成了11个NO供体型马蹄金素衍生物,所有目标产物均未见文献报道,其结构经NMR,ESI-MS确认.以HepG2 2.2.15细胞为乙肝病毒载体,对合成的马蹄金素衍生物进行了抗乙肝病毒活性测试.结果表明,在测试浓度范围内,化合物6d,6e,6g具有抗HBV活性,其半数抑制浓度分别为6.88,37.51,11.07μmol/L.其中,化合物6d和6g的半数抑制浓度优于MTS(11.16μmol/L),且具有较高的抑制率,具有进一步研究开发的价值.     

苯丙烯类葡萄糖氧苷的合成及其抗缺氧活性

以取代苯甲醛(1a~1t)为原料,通过Knoevenagel缩合、酯化和LiAlH₄还原等反应制得苯丙烯醇衍生物(3a~3t);以取代肉桂醛(1u~1x)为原料,经NaBH₄还原制得苯丙烯醇衍生物(3u~3x); 3a~3x与全乙酰化溴代葡萄糖经Koenigs-Knorr偶联反应及MeONa/MeOH体系脱除乙酰保护基反应,合成了24个苯丙烯类葡萄糖氧苷(5a~5x),其中5c,5f ~ 5x为新化合物,其结构经¹H NMR和ESI-MS表征。采用MTT法测定了5对缺氧损伤的内皮细胞(EA.hy926)的抗缺氧活性。实验结果表明： 5b, 5e, 5g, 5p, 5q, 5s, 5t和5y对EA.hy926的抗缺氧活性均高于经景天苷。     

N9位芳基取代嘌呤-8-酮类衍生物的合成及抗肿瘤活性

合成了一系列N9位芳基取代嘌呤-8-酮类衍生物, 利用核磁共振氢谱(¹H NMR)、 核磁共振碳谱(¹³C NMR)和高分辨质谱(HRMS)进行了结构确证. 采用四甲基偶氮唑盐(MTT)法测定了目标化合物的体外抗肿瘤细胞增殖活性. 结果表明, 嘌呤酮环的C2位及N9位的取代对活性有较大影响, C2位引入对位由含氮六元环取代的苯胺, N9位引入对三氟甲基苯均有利于提高抗肿瘤活性. 化合物12c对人白血病细胞(K562)、 人前列腺癌细胞(PC-3)、 人乳腺癌细胞(MDA-MB-231)及人结肠癌细胞(HCT116)的抑制效果明显优于阳性对照药R-Roscovitine.     

Synthesis, properties and molecular structure of a novel dicyanoheptafulvene derivative, 4′-dicyanomethylidenedispiro[cyclohexane-1, 1′-(1′,4′,7′-trihydrocyclopenta[f]azulene)-7′,1″-cyclohexane]

A novel dicyanoheptafulvene 9 annulated by two spiro[4,5]deca-1,3-dienes was synthesized by the reaction of dispirocyclopentaazulenium cation 8 with bromomalononitrile. Although 9 was found to have a nonplanar heptafulvene structure by its X-ray crystallographic analysis, it is still capable of π-conjugation and thus shows appreciable contribution of the dipolar resonance form 9B based on its spectroscopic data. The degree of the contribution was further evaluated for various dicyanoheptafulvenes in terms of the partial sum of atomic charges of the dicyanomethylene group in the calculated structures besides the interplanar angles of the heptafulvene part and the length of the exocyclic double bond in the crystal structures.     

新型螺[氧化吲哚-3,3′-吡唑]-5′-二氟甲基-4′-甲酸酯类化合物的合成

以原位生成的二氟甲基重氮甲烷（CF₂HCHN₂）与靛红衍生的3-烯基氧化吲哚为原料,通过[3+2]环加成反应和1,3-H迁移过程,合成了3种结构新型的螺[氧化吲哚 3,3′-吡唑]-5′-二氟甲基-4′-甲酸酯类化合物,收率41~68%, dr 91: 9~99 : 1,其结构经¹H NMR, ¹³C NMR, ¹⁹F NMR和HR-MS(ESI-TOF)表征。并通过单晶X-射线单晶衍射确定其相对构型。     

3-(1′-烃氧亚氨基)乙基-4-羟基吡咯啉-2-酮类衍生物的合成与生物活性

以氨基酸乙酯为原料合成8种3-乙酰基-4-羟基吡咯啉-2-酮的类似物A, A与3种烃氧基胺盐酸盐反应合成了20个肟醚类衍生物3-(1'-烃氧亚氨基)乙基-4-羟基吡咯啉-2-酮(B), 其结构经 1H NMR, MS, IR和元素分析表征. 初步生物活性测定结果表明合成的化合物B具有一定的除草活性和抑制真菌活性.     

Synthesis of 4′-aryl-2′,3′-dideoxynucleoside analogues

A series of 4′-aryl-2′,3′-dideoxynucleoside analogues were synthesized from optically pure 5-oxo-2-aryl-tetrahydrofuran-2-carboxylic acids up to 62% overall yield. 5-Oxo-2-aryl-tetrahydrofuran-2-carboxylic acids were obtained from 2-hydroxy-3-arylcyclopent-2-en-1-ones by asymmetric oxidation in up to 38-57% yield.     

Synthesis of 1,2′- and 1,3′-bipyrroles from 2- and 3-nitropyrroles

1,2′- and 1,3′-Bipyrroles, which are attractive precursors for the synthesis of bipyrrole-based natural products, are synthesized in one-pot from 2- and 3-nitropyrroles by a sequential nitro group reduction—Paal-Knorr pyrrole synthesis.     

Synthesis of (±)-4′-ethynyl-5′,5′-difluoro-2′,3′-dehydro-3′-deoxy- carbocyclic thymidine: a difluoromethylidene analogue of promising anti-HIV agent Ed4T

Synthesis of (±)-4′-ethynyl-5′,5′-difluoro-2′,3′-dehydro-3′-deoxy-carbocyclic-thymidine (8) was carried out. The difluoromethylylidene group of 8 was constructed by the electrophilic fluorination to the cyclopentenone 11 by using Selectfluor^®. Introduction of thymine base was investigated based on the Mitsunobu reaction by employing cyclopentenyl allyl alcohols variously substituted at the 4-position. It was found the 4-methoxycarbonyl derivative 14 gave the highest selectivity both in terms of regio- and stereochemistry.     

Synthesis of 4′-benzoyloxycordycepin from adenosine

With an aim to synthesize 4′-substituted cordycepins, the 4′-benzoyloxy precursor (9) was prepared from adenosine through an electrophilic addition (iodo-benzoyloxylation) to the 4′,5′-unsaturated derivative (5) and subsequent radical-mediated removal of the 3′-iodine atom of the resulting adducts (6). Usefulness of 9 was briefly verified by synthesizing the 4′-allyl (12) and 4′-cyano (13) analogues of cordycepin.     

Synthesis of (±)-1,2,3-triazolo-3′-deoxy-4′-hydroxymethyl carbanucleosides via ‘click’ cycloaddition

The synthesis of 1,2,3-triazolo-3′-deoxy-4′-hydroxymethyl carbanucleosides with different reaction conditions and diverse modulations on the heterocycle residues was developed. Heterocycle moieties were efficiently introduced on the pseudo-sugar either via nucleophilic substitution or via 1,3-dipolar Huisgen cycloaddition. With this latter approach, 1,4-disubstituted and 1,4,5-trisubstituted-(±)-[1,2,3]-triazolo-3′-deoxy-4′-hydroxymethyl carbanucleosides were prepared from the corresponding azido-carbocycle and various terminal or internal alkynes. Antiviral activities and cellular toxicities of the final compounds were evaluated as smallpox inhibitors. Unfortunately, at concentrations up to 100 mM, none of them inhibited production of vaccinia virus (Lister strain) or cowpox virus (Brighton strain) in vero cells.     

Synthesis of 3′-azido-4′-ethynyl-3′,5′-dideoxy-5′-norarabinouridine: a new anti-HIV nucleoside analogue

3′-Azido-4′-ethynyl-3′,5′dideoxy-5′-norarabinouridine 10 was synthesized from commercial uridine 1 in which the key step is the opening of protected 2′,3′-epoxyuridine derivative 7 by sodium azide and the hydroxymethyl at 4-position of the ribose ring are replaced by ethynyl group.